Stay updated on Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial
Sign up to get notified when there's something new on the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page.

Latest updates to the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision entry (v3.6.4) was added to the study record history, replacing the previous revision (v3.6.3).SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe study record's revision history now includes a new entry for version v3.6.3 and removes the previous v3.6.2 entry, updating the list of recorded revisions to reflect the latest posting.SummaryDifference0.1%

- Check39 days agoChange DetectedA newer revision entry v3.6.2 was added to the record history, and the earlier v3.6.0 entry was removed. This updates the visible version history of the study record.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision entry v3.6.0 was added to the study record history, replacing the previous v3.5.5. This indicates an update to the record's documentation.SummaryDifference0.5%

- Check61 days agoChange DetectedA new revision entry, v3.5.5, was added to the study history, and the previous revision, v3.5.4, was removed.SummaryDifference0.1%

- Check82 days agoChange DetectedThe record history now displays Revision: v3.5.4, replacing the previous v3.5.3. This reflects a minor metadata update to the page's revision history rather than a change to study content.SummaryDifference0.1%

Stay in the know with updates to Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page.